PATENT CLAIM ANALYSIS

Application Number: 16026651
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-04
Patent Classification: ["514", "275000"]

Abstract:
The invention relates to HDAC inhibitors for use in the treatment of diabetic peripheral neuropathy in a subject in need thereof. Also provided herein are methods for treating diabetic peripheral neuropathy in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an HDAC inhibitor.

Claim (Index 7):
The method of  claim 5 , wherein the compound of Formula II is: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 95.0
- Lexical Diversity: 1.57576
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15335971', '14959473', '14792046', '15170335', '14349291']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7535126748874224
- 35 USC 102 Novelty (BERT): 0.5071332230317265
- Combined Prediction Score: 0.7288747297018527
- Mean Citation Score: 202.054092
- Max Citation Score: 263.79025
- Similarity Product: 195.4560744858086

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test